Short communicationDifferential drug binding by the highly conserved Plasmodium falciparum thymidylate synthase
Section snippets
Acknowledgement
Expression system for human TS was kindly provided by D.D. Banerjee of the University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, USA. This work was supported by NIH grants (AI26912 and AI60360) and the UW Keck Center for functional genomics. PKR is an Ellison Medical Foundation Senior Scholar in Global Infectious Diseases.
References (24)
- et al.
Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death
J Biol Chem
(1987) - et al.
Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum
Mol Biochem Parasitol
(1982) - et al.
Folate-based thymidylate synthase inhibitors as anticancer drugs
Ann Oncol
(1995) - et al.
Probing the folate-binding site of human thymidylate synthase by site-directed mutagenesis. Generation of mutants that confer resistance to Raltitrexed, Thymitaq, and BW1843U89
J Biol Chem
(1998) - et al.
High-level expression of human thymidylate synthase
Protein Expr Purif
(1997) - et al.
Essential protein-protein interactions between Plasmodium falciparum thymidylate synthase and dihydrofolate reductase domains
J Biol Chem
(1999) - et al.
Effect of N-terminal truncation of Plasmodium falciparum dihydrofolate reductase on dihydrofolate reductase and thymidylate synthase activity
Mol Biochem Parasitol
(2003) - et al.
Insights into antifolate resistance from malarial DHFR-TS structures
Nat Struct Biol
(2003) - et al.
Prized malaria drug target nailed
Nat Struct Biol
(2003) - et al.
Kinetics of Plasmodium falciparum thymidylate synthase: interactions with high-affinity metabolites of 5-fluoroorotate and D1694
Antimicrob Agents Chemother
(1996)
Potent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparum
Antimicrob Agents Chemother
DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate
Biochemistry
Cited by (6)
Perturbation of genome integrity to fight pathogenic microorganisms
2017, Biochimica et Biophysica Acta - General SubjectsCitation Excerpt :The fusion of the two proteins facilitates dihydrofolate elimination through metabolic channeling and allows sufficient coordinate control of folate metabolizing enzymes, which might represent a biological advantage of such bifunctional DHFR–TSs [156]. The junction of the two proteins is generally not considered as the source of differences in drug actions, which is rather assigned to the sequence diversity [157,158]. Although this flexible linker does not influence the action of classical antifolates it might be a subject of specific inhibitor design, since it modulates enzyme activity in some specific cases [159,160].
Structural biology of plasmodial proteins
2007, Current Opinion in Structural BiologyChemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations
2021, Journal of Medicinal ChemistryHuman dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells
2017, Journal of Biomolecular Structure and DynamicsDiscovery of potent and selective inhibitors of toxoplasma gondii thymidylate synthase for opportunistic infections
2013, ACS Medicinal Chemistry LettersFragment-based discovery of novel thymidylate synthase leads by NMR screening and group epitope mapping
2010, Chemical Biology and Drug Design